We took advantage of Elevance Health's share price weakness in the fourth quarter and added modestly to our investment. Click here to read more.
Shares of Elevance Health Inc. ELV slipped 1.42% to $405.40 Tuesday, on what proved to be an all-around great trading session ...
Sources: FactSet, Dow Jones Stock Movers: Gainers, decliners and most actives market activity tables are a combination of NYSE, Nasdaq, NYSE American and NYSE Arca listings. Sources: FactSet ...
In a report released today, Stephen Baxter from Wells Fargo maintained a Buy rating on Elevance Health (ELV – Research Report), with a price ...
The SPDR Health Care Sector exchange-traded fund, which tracks the health-care industry group of the broad S&P 500, rose by roughly 2%, and is now up about 7% for the year to date.
Elevance Health Inc. closed 27.50% below its 52-week high of $567.26, which the company achieved on September 3rd.
US stocks showed mixed signals in premarket trading on Thursday. Futures for the S&P 500 lost 0.1% before the opening bell, ...
The Dow Jones index rose but other indexes lagged in the stock market today. Yield rose as investors awaited Trump's Davos address.
Stocks headed toward all-time highs as oil fell after President Donald Trump urged OPEC to lower crude prices and said he will push for interest-rate cuts.